allulose effect on glp 1 GLP-1 Release by Rare Sugar D-Allulose Ameliorates Sucrose-Induced Obesity and Glucose Intolerance in Ovariectomized Mice GLP-1 Release by Rare Sugar

See how ADA and NICE compare on screening, glycemic targets, CGM, and the latest treatment strategies for real-world practice

Suggested Use Take 1 capsule daily with a meal, or as recommended by your healthcare provider

(1:45) Once a child of God, always a child of God

Promotes Regularity*

An observational study in Neurology found that GLP1 diabetes drugs were associated with a lower risk of developing epilepsy compared with DPP4 inhibitors

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron